Warren Buffett sells the drugstore but maintains his trust in Apple

Warren Buffett, the famous American investor, is decidedly not convinced by the pharmacy sector. In the second quarter, he sold 1.2 billion shares of pharmaceutical groups, according to figures released a few days ago. As in the previous quarter, Berkshire Hathaway reduced its investments in Merck, Bristol Myers Squibb and Abbvie. Titles which have nevertheless progressed by 1%, 3% and 6% respectively since June 30.

The billionaire had made a foray into pharmaceutical stocks quite late, in the third quarter of 2020 and for $ 5 billion. For more than 25 years, Warren Buffett has questioned the merits of this sector that he has difficulty in understanding. He had always hesitated until then. He had not invested in particular because of the excessively high prices of the giants of the sector. The global pandemic will have changed his mind, but he has already sold half of his stake in this field in the first half of the year. In particular, it sold its entire stake in biotech Biogen, taking advantage of the 25% jump in its share price in the second quarter.

Leave a Reply

Your email address will not be published. Required fields are marked *